A systematic review and meta-analysis of clinical outcomes of Takotsubo syndrome in patients with cancer

Back

ESC Professional Premium Access

A systematic review and meta-analysis of clinical outcomes of Takotsubo syndrome in patients with cancer

Session: Cardiomyopathies in myocardial disease

Topic: Takotsubo Cardiomyopathy

Speaker: Doctor T. Osawa (Tsukuba, JP)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Takumi Osawa

Tsukuba University Hospital, Tsukuba (Japan)

0 follower

7 more presentations in this session

Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)

Speaker: Doctor N. Lakdawala (Boston, US)

Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial

Speaker: Doctor H. Procter (Leeds, GB)

Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up

Speaker: Doctor M. Schiavo (Bologna, IT)

Association between hospital volume, clinical events, resource utilization, and costs of septal myectomy and alcohol septal ablation procedures in US patients with hypertrophic cardiomyopathy

Speaker: Doctor E. Maksabedian Hernandez (Los Angeles, US)

Electrocardiographic evolution in Anderson-Fabry disease: a valuable tool to detect progressive cardiac involvement

Speaker: Doctor R. Baldassarre (Bologna, IT)

Access the full session

Cardiomyopathies in myocardial disease

Speakers: Doctor T. Osawa, Doctor N. Lakdawala, Doctor H. Procter, Doctor M. Schiavo, Doctor E. Maksabedian Hernandez...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

A systematic review and meta-analysis of clinical outcomes of Takotsubo syndrome in patients with cancer

About the speaker

Doctor Takumi Osawa

7 more presentations in this session

Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)

Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial

Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up

Association between hospital volume, clinical events, resource utilization, and costs of septal myectomy and alcohol septal ablation procedures in US patients with hypertrophic cardiomyopathy

Electrocardiographic evolution in Anderson-Fabry disease: a valuable tool to detect progressive cardiac involvement

Access the full session

Cardiomyopathies in myocardial disease

About the event

ESC Congress 2023

ESC 365 is supported by